Dissipation and removal of oseltamivir (Tamiflu) in different aquatic environments

Chemosphere

Volumn 79, Issue 8, 2010, Pages 891-897

  Accinelli, Cesare ^a   Saccà, Maria Ludovica ^a   Fick, Jerker ^b   Mencarelli, Mariangela ^a   Lindberg, Richard ^b   Olsen, Björn ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UMEÅ UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bioremediation; H1N1; H5N1; Pharmaceuticals; Surface water; Wastewater

Indexed keywords

BIOREMEDIATION; DRUG PRODUCTS; EFFLUENTS; ELECTROPHORESIS; HYDROGEOLOGY; MINERALOGY; POLYMERASE CHAIN REACTION; RECLAMATION; SEWAGE PUMPING PLANTS; VIRUSES; WASTEWATER; WASTEWATER TREATMENT; WATER TREATMENT PLANTS;

DENATURING GRADIENT GEL ELECTROPHORESES (DGGE); H1N1; H5N1; LABORATORY EXPERIMENTS; MICROBIAL POPULATIONS; MUNICIPAL WASTEWATER TREATMENT PLANTS; WASTEWATER TREATMENT PLANTS; WATER AND WASTEWATER SAMPLES;

SURFACE WATERS;

OSELTAMIVIR; SURFACE WATER;

BIOREMEDIATION; DISSIPATION; DRUG; ECOSYSTEM; EFFLUENT; EXPERIMENTAL STUDY; INCUBATION; INFLUENZA; INOCULATION; LABORATORY METHOD; MICROBIAL ACTIVITY; MINERALIZATION; RESEARCH WORK; SURFACE WATER; WASTEWATER; WATER POLLUTION; WATER TREATMENT;

AQUATIC ENVIRONMENT; ARTICLE; BACTERIAL STRAIN; BIODEGRADATION; BIOMINERALIZATION; CARBON SOURCE; CONTROLLED STUDY; EFFLUENT; ITALY; JAPAN; NONHUMAN; TANK; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

ITALY; JAPAN;

BACTERIA (MICROORGANISMS); ORTHOMYXOVIRIDAE;

EID: 77951652963     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2010.02.022     Document Type: Article

References (33)

1. Accinelli C., Barra Caracciolo A., Grenni P. Degradation of the antiviral drug oseltamivir carboxylate in surface water samples. Int. J. Environ. Anal. Chem. 2007, 87:579-587.
2. Bartels P., von Tümpling W. The environmental fate of the antiviral drug oseltamivir carboxylate in different waters. Sci. Total Environ. 2008, 405:215-225.
3. Brandt K.K., Jørgensen N.O.G., Nielsen T.H., Winding A. Microbial community-level toxicity testing of linear alkylbenzene sulfonates in aquatic microcosms. FEMS Microbiol. Ecol. 2004, 49:229-241.
4. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 77:1257-1274.
5. Carballa M., Omil F., Lema J.M. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere 2008, 72:1118-1123.
6. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients. Sci. Total Environ. 2006, 364:67-87.
7. Christian T., Schneider R.J., Färber H.A., Skutlarek D., Meyer M.T., Goldbach H.E. Determination of antibiotic residues in manure, soil, and surface waters. Acta Hydrochim. Hydrobiol. 2003, 31:36-44.
8. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Persp. 1999, 107:907-938.
9. Dietrich D.R., Webb S.F., Petry T. Hot spot pollutants: pharmaceuticals in the environment. Toxicol. Lett. 2002, 131:1-3.
10. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
11. Fick J., Lindberg R.H., Tysklind M., Haemig P.D., Waldenström J., Wallensten A., Olsen B. Antiviral oseltamivir is not removed or degraded in normal sewage water treatment: implications for development of resistance by influenza A virus. PLoS ONE 2007, 3:e986.
12. Fierer N., Jackson J.A., Vilgalys R., Jackson R.B. Assessment of soil microbial community structure by use of taxon-specific quantitative PCR assays. Appl. Environ. Microbiol. 2005, 71:4117-4120.
13. Ghosh, G.C., Nakada, N., Yamashita, N., Tanaka, H., 2009. Oseltamivir carboxylate - The active metabolite of oseltamivir phosphate (Tamiflu), detected in sewage discharge and river water in Japan. Environ. Health Persp. doi:10.1289/ehp.0900930.
14. Harms G., Layton A.C., Dionisi H.M., Gregory I.R., Garrett V.M., Hawkins S.A., Robinson K.G., Sayler G.S. Real-time PCR quantification of nitrifying bacteria in a municipal wastewater treatment plant. Environ. Sci. Technol. 2003, 37:343-351.
15. Hutchinson T.H., Beesley A., Frickers P.E., Readman J.W., Shaw J.P., Straub J.O. Extending the environmental risk assessment for oseltamivir (Tamiflu®) under pandemic use conditions to the coastal marine compartment. Environ. Int. 2009, 35:931-936.
16. Kawai F., Yamanaka H. Biodegradation of polyethylene glycol by symbiotic mixed culture (obligate mutualism). Arch. Microbiol. 1986, 146:125-129.
17. Kim Y.S., Min J., Hong H.N., Park J.H., Park K.S., Gu M.B. Gene expression analysis and classification of mode of toxicity of polycyclic aromatic hydrocarbons (PAHs) in Escherichia coli. Chemosphere 2007, 66:1243-1248.
18. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zargg S.D., Barber L.B., Buxton M.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36:1202-1211.
19. Kümmerer K. Antibiotics in the aquatic environment - A review - Part I. Chemosphere 2009, 75:417-434.
20. Kümmerer K., Henninger A. Promoting resistance by the emission of antibiotics from hospitals and households into effluents. Clin. Microbiol. Infect. 2003, 9:1203-1214.
21. Matamoros V., Hijosa M., Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 2009, 75:200-205.
22. Saccà M.L., Accinelli C., Fick J., Lindberg R., Olsen B. Environmental fate of the antiviral drug Tamiflu in two aquatic environments. Chemosphere 2009, 75:28-33.
23. Singer A.C., Nunn M.A., Gould E.A., Johnson A.C. Potential risks associated with the widespread use of Tamiflu. Environ. Health Persp. 2007, 115:102-106.
24. Singer A.C., Howard B.M., Johnson A.C., Knowles C.J., Jackman S., Accinelli C., Barra Caracciolo A., Bernard I., Bird S., Boucard T., Boxall A., Brian J., Cartmell E., Chubb C., Churchley J., Costigan S., Crane M., Dempsey M.J., Dorrington B., Fick J., Holmes J., Hutchinson T., Karcher F., Kelleher S.L., Marsden P., Noone G., Nunn M.A., Oxford J., Rachwal T., Roberts N., Roberts M., Saccà M.L., Sanders M., Straub J.O., Terry A., Thomas D., Toovey S., Townsend R., Voulvoulis N., Watts C., Wells U. Assessment of Tamiflu® release to the environment under pandemic conditions. Report from an interdisciplinary workshop. Environ. Health Persp. 2008, 116:1563-1567.
25. Söderstrom H., Järhult J.D., Olsen B., Lindberg R.H., Tanaka H., Fick J. Detection of the antiviral drug oseltamivir in aquatic environments. PLoS ONE 2009, 4:e6064.
26. Soong G., Muir A., Gomez M.I., Waks J., Reddy B., Planet P., Singh P.K., Kaneko Y., Wolfgang M.C., Hsiao Y.S., Tong L., Prince A. Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production. J. Clin. Invest. 2006, 116:2297-2305.
27. Straub J.O. An environmental risk assessment for oseltamivir (Tamiflu®) for sewage works and surface waters under seasonal-influenza- and pandemic-use conditions. Ecotox. Environ. Safe. 2009, 72:1625-1634.
28. Terners T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol. 2004, 38:392-399.
29. Taylor G. Sialidases: structures, biological significance and therapeutic potential. Curr. Opin. Struct. Biol. 1996, 6:830-837.
30. von Itzstein M. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug. Discov. 2007, 6:967-974.
31. Ward P., Small I., Smith J., Suter P., Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J. Antimicrob. Chemoth. 2005, 55:5-21.
32. Willems A., Collins M.D. Phylogenetic relationships of the genera Acetobacterium and Eubacterium sensu stricto and reclassification of Eubacterium alactolyticum as Pseudoramibacter alactolyticus. Int. J. Syst. Bacteriol. 1996, 46:1083-1087.
33. Zhang Y.J., Geißen S.-U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.